EndMT contributes to the onset and progression of cerebral cavernous malformations. [electronic resource]
Producer: 20130716Description: 492-6 p. digitalISSN:- 1476-4687
- Animals
- Bone Morphogenetic Protein 6 -- antagonists & inhibitors
- Disease Models, Animal
- Disease Progression
- Epithelial-Mesenchymal Transition -- drug effects
- Hemangioma, Cavernous, Central Nervous System -- genetics
- Humans
- KRIT1 Protein
- Mice
- Microtubule-Associated Proteins -- deficiency
- Proto-Oncogene Proteins -- deficiency
- Signal Transduction -- drug effects
- Transforming Growth Factor beta -- antagonists & inhibitors
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.